FABP4 and prostate adenocarcinoma: Notably, the mean prostate weight (105.8 ± 16.4 and 156.1 ± 68.1 mg); incidence rates of primary prostate adenocarcinoma (33.4% and 63.7%), venule metastasis (22.2% and 45.4%), and lung metastasis (0% and 36.3%); and the level of periprostatic adipocyte infiltration were lower in HF-fed FABP4−/− TRAMP mice than in TRAMP mice (Figure 3A,B).